PEBC - Programa de Epigenética y Biología del Cáncer 
     
Historical
 
  <
  NEWS PEBC 
 

12/02/16
Manel Esteller receives the National Research Prize 2015
 

12/02/16
Eva Gonzalez Suarez gets Consolidator Grant from the European Research Council
 

13/05/15
Manel Esteller receives Josep Trueta health merit medal
 
 
 

 

films

PEBC update

Aseica

 

 

The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info

  LAST PUBLICATIONS  
 

Nature Medicine - Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGF >>

 

Genome Biology - Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer >>

 

Oncogene - . Gene Amplification-Associated Overexpression of the RNA Editing Enzyme ADAR1 Enhances Human Lung T >>

 

 

 

 

 

 

lectures-2011

ICC

 

 

 

 

 
Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme ERC Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia
 
 

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP